Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon

2005 ◽  
Vol 40 (2) ◽  
pp. 148-156 ◽  
Author(s):  
Masafumi Ikeda ◽  
Shigetoshi Fujiyama ◽  
Motohiko Tanaka ◽  
Michio Sata ◽  
Tatsuya Ide ◽  
...  
Keyword(s):  
Risk Factors ◽  
Hepatocellular Carcinoma ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Sustained Response

Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C

2010 ◽  
Vol 40 (9) ◽  
pp. 911-922 ◽  
Author(s):  
Nobuyoshi Fukushima ◽  
Ryoko Kuromatsu ◽  
Teruko Arinaga-Hino ◽  
Eiji Ando ◽  
Akio Takata ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Sustained Response

Risk Factors of Hepatocellular Carcinoma in Chronic Hepatitis C and Cirrhosis: Special Reference to Laparoscopic Findings

1999 ◽  
Vol 11 (1) ◽  
pp. 24-31 ◽  
Author(s):  
Takao SHIBAYAMA ◽  
Shin‐iciro MORI ◽  
Hiroo OHTAKE ◽  
Seishuu HAYASHI ◽  
Shunichi SAEKI ◽  
...  
Keyword(s):  
Risk Factors ◽  
Hepatocellular Carcinoma ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Special Reference ◽  
Chronic Hepatitis C

Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy

Cancer ◽  
2004 ◽  
Vol 101 (7) ◽  
pp. 1616-1622 ◽  
Author(s):  
Akiko Makiyama ◽  
Yoshito Itoh ◽  
Akinori Kasahara ◽  
Yasuharu Imai ◽  
Sumio Kawata ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Interferon Therapy ◽  
Sustained Response

scholarly journals Patients with Chronic Hepatitis C - Who Should Not Be Treated?

2000 ◽  
Vol 14 (suppl b) ◽  
pp. 63B-67B
Author(s):  
Andreas Schüler ◽  
Michael Peter Manns
Keyword(s):  
Risk Factors ◽  
Hepatocellular Carcinoma ◽  
Liver Cirrhosis ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Treatment Side Effects ◽  
Life Conditions ◽  
Therapy Effectiveness ◽  
Receive Treatment

The decision to treat a patient with chronic hepatitis C (CHC) is based on what is known about the risk factors for developing liver cirrhosis or hepatocellular carcinoma, as well as on conditions that contraindicate therapy or impair therapy effectiveness. Several factors, including age, treatment side effects, disease severity, concurrent diseases and life conditions, may render treatment decisions more difficult. This review focuses on identifying CHC patients who should not receive treatment.

Sign in / Sign up

Export Citation Format

Share Document